Cataract risk up for statin users with type 2 diabetes

August 13, 2012
Cataract risk up for statin users with type 2 diabetes
Statin use, which is substantially higher in patients with type 2 diabetes, correlates with an increased risk of age-related cataracts, according to a study published in the August issue of Optometry and Vision Science.

(HealthDay) -- Statin use, which is substantially higher in patients with type 2 diabetes, correlates with an increased risk of age-related (AR) cataracts, according to a study published in the August issue of Optometry and Vision Science.

Noting that diabetes is a risk factor for AR , Carolyn M. Machan, O.D., from the University of Waterloo in Canada, and colleagues examined the association between AR cataract, , and reported statin use in a large cohort. The prevalence of statin use was assessed for the 452 patients with type 2 diabetes and the 5,884 patients without diabetes.

The researchers found that, for patients older than 38 years, the prevalence of statin use was 56 percent for those with type 2 diabetes and 16 percent for those without diabetes. There was a significant correlation between type 2 diabetes and nuclear sclerosis (odds ratio [OR], 1.62) and (OR, 1.37). There was a significant correlation between statin use and nuclear sclerosis and posterior subcapsular cataract (OR, 1.48 for both). In statin users the 50 percent probability of cataract occurred at age 51.7 for those with type 2 diabetes and at age 54.9 for those without diabetes. The ages were significantly older (55.1 and 57.3 years, respectively) for non-statin users.

"Regardless of the outcome of further study, the benefits of statin use in people with type 2 diabetes are anticipated to continue to outweigh any associated increased risk of AR cataract," the authors write. "Information provided here can serve public health efforts to educate people on the risks of treatments associated with type 2 diabetes."

Explore further: Statin use in postmenopausal women associated with increased diabetes risk

More information: Abstract
Full Text

Related Stories

Statin use in postmenopausal women associated with increased diabetes risk

January 9, 2012
The use of statins in postmenopausal women is associated with increased diabetes risk, according to a study published Online First by the Archives of Internal Medicine.

Intensive-dose statin therapy associated with increased risk of diabetes

June 21, 2011
An analysis of data from previously published studies indicates that intensive-dose statin therapy is associated with an increased risk of new-onset diabetes compared with moderate-dose therapy, according to a study in the ...

Type 2 diabetes linked to higher risk of stroke and CV problems; metabolic syndrome isn't

June 13, 2011
Among patients who have had an ischemic stroke or transient ischemic attack (TIA), type 2 diabetes was associated with an increased risk of recurrent stroke or cardiovascular events, but metabolic syndrome was not, according ...

Cardiovascular benefits of taking statins outweigh diabetes risk

August 9, 2012
The benefits of taking statins to reduce the risk of cardiovascular disease outweigh the increased risk of developing diabetes experienced by some patients who take these cholesterol-lowering drugs, according to an Article ...

Polycystic ovarian syndrome ups risk of type 2 diabetes

June 22, 2012
(HealthDay) -- Middle-aged women with polycystic ovary syndrome (PCOS) are at increased risk of developing type 2 diabetes, according to a prospective long-term study published online June 14 in Diabetes.

Recommended for you

People who drink 3 to 4 times per week less likely to develop diabetes than those who never drink: study

July 27, 2017
Frequent alcohol consumption is associated with a reduced risk of diabetes in both men and women, according to a new study published in Diabetologia (the journal of the European Association for the Study of Diabetes), with ...

Diabetes can be tracked with our Google searches

July 26, 2017
The emergence of Type 2 Diabetes could be more effectively monitored using our Google searches—helping public health officials keep track of the disease and halt its spread—according to research by the University of Warwick.

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.